Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
-
121
-
122
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(F-G) Representative western blots and summarized bar graph showed EVO significantly increased protein expression of SM22α and decreased RUNX2 in CER treated P<sub>i</sub>-induced VSMCs. …”
-
123
-
124
-
125
Publication bias of the risk of all groups.
Published 2025“…A fixed-effects model was applied if P > 0.1 and I<sup>2</sup> ≤ 50%; otherwise, a random-effects model was used to account for significant heterogeneity Publication bias was assessed using funnel plots and Egger’s test. …”
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: “…treatment initiation decreased…”
-
134
-
135
-
136
Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.
Published 2025Subjects: -
137
-
138
-
139
-
140